Beneficial effect of low-dose transdermal estrogen on bleeding time and clinical bleeding in uremia
- 31 July 1995
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 26 (1) , 22-26
- https://doi.org/10.1016/0272-6386(95)90148-5
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Reduction of platelet glycoprotein Ib in uraemiaBritish Journal of Haematology, 1991
- Effects of Recombinant Human Erythropoietin and Correction of Anemia on Platelet Function in Hemodialysis PatientsNephron, 1991
- Dose-effect and pharmacokinetics of estrogens given to correct bleeding time in uremiaKidney International, 1988
- Conjugated Estrogens for the Management of Bleeding Associated with Renal FailureNew England Journal of Medicine, 1986
- Biologic Effects of Transdermal EstradiolNew England Journal of Medicine, 1986
- Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusionsBritish Journal of Haematology, 1985
- TREATMENT OF URAEMIC BLEEDING WITH CONJUGATED OESTROGENThe Lancet, 1984
- Deamino-8-D-Arginine Vasopressin Shortens the Bleeding Time in UremiaNew England Journal of Medicine, 1983
- Treatment of the Bleeding Tendency in Uremia with CryoprecipitateNew England Journal of Medicine, 1980
- Estrophile to nucleophile in two easy stepsJournal of Steroid Biochemistry, 1972